Revvity | PKI - 普通股股本



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 15.15B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


普通股股本 更改 日
Agilent USD 281.97M 252K 2026-06
Align Technology USD 71.62M 1000 2026-06
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.35M 130K 2026-06
Celltrion KRW 229.65M 11.03M 2026-03
Charles River Laboratories USD 47.73M 439K 2026-06
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 199.2M 1.1M 2026-06
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Divis Laboratories Ltd INR 265.47M 0 2026-03
Edwards Lifesciences USD 577M 3.7M 2026-03
Illumina USD 151.3M 607K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 80.9M 1.4M 2026-06
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Organigram Holdings CAD 136.47M 1.34M 2026-03
Ovoca Bio EUR 29.49M 0 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pharma Mar EUR 17.34M 24.24K 2026-06
Qiagen NV USD 206.5M 245K 2026-06
Quest Diagnostics USD 110M 1000K 2026-06
Quidel USD 68.1M 200K 2026-03
Repligen USD 56.43M 28K 2026-06
Revvity USD 111.63M 174K 2026-06
Sartorius EUR 69.05M 0 2026-06
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Tilray USD 116.52M 5.01M 2025-09
Waters USD 98.19M 20K 2026-06
Zealand Pharma A/S 70.66M 53K 2026-03
Zz Pientze Pharmaceu CNY 603.32M 0 2026-06